| Literature DB >> 26278702 |
Bekir Hacioglu1, Serkan Akin1, Ali R Sever2, Kadri Altundag1.
Abstract
Entities:
Keywords: HER2-positive; adjuvant; breast cancer; chemotherapy; complete remission; intratumoral heterogeneity; locally advanced; neoadjuvant; receptors; trastuzumab
Mesh:
Substances:
Year: 2015 PMID: 26278702 DOI: 10.2217/fon.15.164
Source DB: PubMed Journal: Future Oncol ISSN: 1479-6694 Impact factor: 3.404